Has Sara Husain, MD received payments from drug or device companies?

Yes. Drug and device makers reported $290 in general payments to Sara Husain, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sara Husain, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sara Husain, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sara Husain, MD

Nephrology · Snellville, GANPI 1912285701

Payments from drug & device makers

$290in general payments, 2019–2025

Across 15 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Akebia Therapeutics Inc$58
Amgen$52
Otsuka America Pharmaceutical, Inc.$36
Calliditas Therapeutics US Inc.$23
Fresenius USA Marketing, Inc.$21
ANI Pharmaceuticals, Inc.$19
plus $81 from 5 others

What the payments were for

Food & beverage$290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Akebia Therapeutics Inc	2	$58
Amgen	3	$52
Otsuka America Pharmaceutical, Inc.	2	$36
Calliditas Therapeutics US Inc.	1	$23
Fresenius USA Marketing, Inc.	1	$21
ANI Pharmaceuticals, Inc.	1	$19
Aurinia Pharma U.S., Inc.	1	$19
Boehringer Ingelheim	1	$18
Bayer	1	$17
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$14
GSK	1	$13

How this compares

$290 in reported general payments places this provider in the 20th percentile of 388 nephrology providers in Georgia.

See all nephrology providers in Georgia →

Medicare billing

Part B allowed, 2024

$353,209

Medicare patients

783

Services billed

2,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FarxigaDapagliflozin Propanediol	126	$76,628
VeltassaPatiromer Calcium Sorbitex	14	$25,932
EliquisApixaban	15	$13,870
JanuviaSitagliptin Phosphate	18	$13,141
Allopurinol	83	$1,756
Potassium Chloride	24	$1,389
Sevelamer Carbonate	18	$1,277
Losartan Potassium	73	$1,120
Midodrine Hcl	13	$847
Tamsulosin Hcl	19	$324
Amlodipine Besylate	34	$312
Metoprolol Succinate	24	$193
Hydrochlorothiazide	63	$177
Lisinopril	39	$121
Furosemide	44	$88

Paid to pharmacies, not to this prescriber.

Other nephrology in Snellville

James TumlinLawrenceville$19.8M
Chinedu NwekeAcworth$3.9M
Vinayak RamanathLagrange$3.1M
Harold HubertAugusta$2.8M
Tamorie SmithColumbus$1.9M
Barton BrezinaAugusta$1.5M
Frederic Rahbari OskouiAtlanta$1.5M
Rajeev ChauhanColumbus$1.1M
Sagar PanseMacon$1.1M
Laura MulloyAugusta$891K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →